T1	Participants 54 85	chronic hepatic encephalopathy.
T2	Participants 137 173	The Italian Multicenter Study Group.
T3	Participants 292 336	chronic hepatic encephalopathy in cirrhosis.
T4	Participants 410 570	patients were administered, in addition to their diet, branched-chain amino acids (0.24 g/kg, 30 patients) or an equinitrogenous amount of casein (34 patients).
T5	Participants 1683 1730	cirrhotic patients with chronic encephalopathy.
